stockrowInteger Holdings Corporation (ITGR) vs 10x Genomics (TXG)
- Integer Holdings Corporation ITGR 126.54 −0.17%
- 10x Genomics TXG 58.85 +1.36%
Integer Holdings Corporation and 10x Genomics are both Medical Devices companies. 10x Genomics is the larger, with a market value of $7.6B against $4.3B — 1.8× the size. 10x Genomics has negative trailing earnings, so its P/E is not meaningful; Integer Holdings Corporation trades at 42.2×. Integer Holdings Corporation grew revenue faster over the last twelve months: −0.31% against −4.28%. Integer Holdings Corporation has the higher net margin (5.68% vs −12.2%) and the higher return on invested capital (3.16% vs −20.2%). Across the 20 metrics below, Integer Holdings Corporation leads on 14 and 10x Genomics on 6.
Valuation
Profitability
| Metric | ITGR | TXG | Medical Devices median |
|---|---|---|---|
| Gross margin | 24.59% | 70.03% | 57.76% |
| Operating margin | 8.25% | (14.33%) | (15.07%) |
| Net margin | 5.68% | (12.18%) | (14.45%) |
| Free cash flow margin | 4.48% | 19.68% | (3.88%) |
| Return on equity | 5.97% | (9.40%) | (10.35%) |
| Return on assets | 3.05% | (7.47%) | (17.26%) |
| Return on invested capital | 3.16% | (20.20%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack